401. [Mediterranean boutonneuse fever. Apropos of 154 recent cases].
- Author
-
Raoult D, Jean-Pastor MJ, Xeridat B, Garnier JM, Weiller PJ, Garcin G, Privat Y, Gallais H, and Casanova P
- Subjects
- Adolescent, Adult, Aged, Anti-Bacterial Agents therapeutic use, Boutonneuse Fever drug therapy, Boutonneuse Fever epidemiology, Child, Child, Preschool, Female, France, Humans, Infant, Infant, Newborn, Male, Middle Aged, Retrospective Studies, Tetracyclines therapeutic use, Boutonneuse Fever diagnosis, Rickettsiaceae Infections diagnosis
- Abstract
The Mediterranean spotted fever is always present in the south of France. The actual incidence is unknown. The disease appears in summer. The diagnostic is based on the association of fever, "black spot" and exanthema and/or a seroconversion. Indirect immunofluorescence is the most used technique. Some patients have severe complications: neurologic, cardiovascular, renal, thrombopenia. These cases look like Rocky Mountain Spotted Fever. The treatment is based on tetracycline.
- Published
- 1983